Herpes virus infections amongst moderate to severe atopic dermatitis patients treated with baricitinib: an integrated analysis of phase 3 trials

被引:0
作者
Werfel, T. [1 ]
Irvine, A. D. [2 ]
Bangert, C. [3 ]
Seneschal, J. [4 ]
Grond, S. [5 ]
Cardillo, T. [5 ]
Brinker, D. [5 ]
Zhong, J. [6 ]
Riedl, E. [5 ]
Wollenberg, A. [7 ]
机构
[1] Hannover Med Sch, Hannover, Germany
[2] Trinity Coll Dublin, Dublin, Ireland
[3] Med Univ Vienna, Vienna, Austria
[4] Hop St Andre, Bordeaux, France
[5] Eli Lilly & Co, Indianapolis, IN USA
[6] IQVIA, Durham, NC USA
[7] Ludwig Maximillian Univ, Munich, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
084
引用
收藏
页码:S162 / S162
页数:1
相关论文
共 50 条
[41]   Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials [J].
Zirwas, Matthew J. ;
Boguniewicz, Mark ;
Rosmarin, David ;
Fuxench, Zelma Chiesa ;
Warren, Richard B. ;
Torres, Tiago ;
de Bruin-Weller, Marjolein ;
Dawson, Zach ;
Atwater, Amber Reck ;
Elmaraghy, Hany ;
Pierce, Evangeline ;
Bardolet, Laia ;
Zhong, Jinglin ;
Armstrong, April W. .
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 :54-56
[42]   Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics [J].
Thyssen, J. P. ;
Thaci, D. ;
Bieber, T. ;
Gooderham, M. ;
de Bruin-Weller, M. ;
Soong, W. ;
Kabashima, K. ;
Barbarot, S. ;
Luna, P. C. ;
Xu, J. ;
Hu, X. ;
Liu, Y. ;
Raymundo, E. M. ;
Calimlim, B. M. ;
Nduaka, C. ;
Gamelli, A. ;
Simpson, E. L. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, :1871-1880
[43]   Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab [J].
de Bruin-Weller, M. ;
Eckert, L. ;
Simpson, E. L. ;
Cork, M. J. ;
Ardeleanu, M. ;
Chen, Z. ;
Shumel, B. ;
Rossi, A. B. ;
Graham, N. M. H. ;
Pirozzi, G. ;
Gadkari, A. .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 :116-116
[44]   Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis [J].
Marcant, P. ;
Balaye, P. ;
Merhi, R. ;
Jendoubi, F. ;
Nosbaum, A. ;
Raison-Peyron, N. ;
Du-Thanh, A. ;
Lasek, A. ;
Ferrier le Bouedec, M. -C. ;
Tetart, F. ;
Valois, A. ;
Barbarot, S. ;
Soria, A. ;
Jachiet, M. ;
Staumont-Salle, D. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (06) :E394-E396
[45]   Lebrikizumab improvement in itch reduction at 52 weeks in patients with moderate-to-severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials [J].
Yosipovitch, Gil ;
Lio, Peter ;
Rosmarin, David ;
Legat, Franz ;
Carrascosa, Jose Manuel ;
Meskimen, Eric ;
Casillas, Marta ;
Pierce, Evangeline ;
Liu, Zhuqing ;
Zhong, Jinglin ;
Staender, Sonja .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) :AB188-AB188
[46]   Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic Dermatitis [J].
Paller, Amy S. ;
Eichenfield, Lawrence F. ;
Irvine, Alan D. ;
Flohr, Carsten ;
Wollenberg, Andreas ;
Barbarot, Sebastien ;
Bangert, Christine ;
Spergel, Jonathan M. ;
Selfridge, Andrew ;
Biswas, Pinaki ;
Fan, Haiyun ;
Alderfer, Justine ;
Watkins, Melissa ;
Koppensteiner, Herwig .
ALLERGY, 2025,
[47]   Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis - a meta-analysis of randomized clinical trials [J].
Marko, Monika ;
Pawliczak, Rafal .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (01) :121-134
[48]   Extended safety analysis of baricitinib 2-mg in adult patients with atopic dermatitis: An integrated analysis from 8 randomized clinical trials [J].
King, Brett ;
Maari, Catherine ;
Lain, Edward ;
Silverberg, Jonathan I. ;
Issa, Maher ;
Holzwarth, Katrin ;
Brinker, Dennis ;
Cardillo, Tracy ;
Nunes, Fabio P. ;
Simpson, Eric L. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) :AB127-AB127
[49]   Herpes simplex history, serology, and symptomatic infections in patients treated with topical tacrolimus for atopic dermatitis [J].
Lübbe, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (03) :760-760
[50]   Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial [J].
Wollenberg, A. ;
Nakahara, T. ;
Maari, C. ;
Peris, K. ;
Lio, P. ;
Augustin, M. ;
Silverberg, J. I. ;
Rueda, M. J. ;
DeLozier, A. M. ;
Pierce, E. ;
Yang, F. E. ;
Sun, L. ;
Ball, S. ;
Tauber, M. ;
Paul, C. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (07) :1543-1552